Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.209 EUR | +1.28% | +4.60% | +8.91% |
Business Summary
Number of employees: 1,086
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Transformative Medicines Based on Messenger Ribonucleic Acid
100.0
%
| 71 | 100.0 % | 58 | 100.0 % | -17.98% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Belgium
87.7
%
| 65 | 92.4 % | 51 | 87.7 % | -22.14% |
Switzerland
10.1
%
| 4 | 5.0 % | 6 | 10.1 % | +65.60% |
Netherlands
2.2
%
| 2 | 2.7 % | 1 | 2.2 % | -31.10% |
Others
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 27/03/23 | |
Pierre Kemula
DFI | Director of Finance/CFO | 50 | 31/10/16 |
Malte Greune
COO | Chief Operating Officer | 59 | 30/06/21 |
Sarah Fakih
IRC | Investor Relations Contact | - | - |
Myriam Mendila
PRN | Corporate Officer/Principal | 58 | 31/01/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 31/05/19 |
Michael Brosnan
BRD | Director/Board Member | 69 | 18/06/23 |
Director/Board Member | 67 | 21/06/22 | |
Chairman | 73 | 31/07/15 | |
Mathias Hothum
BRD | Director/Board Member | 58 | 31/07/15 |
Director/Board Member | 61 | 21/06/22 | |
Viola Bronsema
BRD | Director/Board Member | 61 | 31/07/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 224,305,680 | 122,763,011 ( 54.73 %) | 0 | 54.73 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+40.97% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CVAC Stock
- 5CV Stock
- Company CureVac N.V.